Mike O’Brien, 73, was fortunate to join a clinical trial for a new Alzheimer’s treatment for those in the early stages of the disease. Still, he and his wife worry about the day the trial ends and they will be on the hook to pay for the exorbitantly priced monthly infusion. The Food and Drug… Read More »
[unable to retrieve full-text content]NHS England calls for a clamp down on the targeting of the “dangerous” unlicensed drug at young women. BBC News – Health
Researchers have identified a critical mechanism that allows deadly bacteria to gain resistance to antibiotics. The findings offer a potential new drug target in the search for effective new antibiotics as we face the growing threat of antimicrobial resistance (AMR) and infections caused by bacterial pathogens. The study investigated quinolone antibiotics which are used to… Read More »
Many times through the years, HealthNewsReview.org has criticized the National Press Foundation in Washington, DC, for accepting drug company funding for journalism training. (See articles from June 2009, July 2009, August 2010, September 2010, October 2010, March 2014, March 2015, December 2015, November 2019. I may have missed a few, but you get the picture.) They’re doing it… Read More »
Article content continued We feel that everyone is blaming someone else and patients are caught in the middle Vertex has done spectacularly well from Trikafta this year, reporting sales of US$ 918 million in second quarter of this year, from zero last year. That helped the company’s net income to soar 213 per cent year… Read More »
By CECI CONNOLLY and BOBBY CLARK We are all are anxiously awaiting the approval and delivery of a cure to the novel coronavirus – or better yet, a vaccine. Amid the race to develop a safe and effective vaccine, some may be inclined to give drug companies a pass on their well-established bad behavior related… Read More »
Researchers at Beth Israel Deaconess Medical Center are testing a new approach to fighting COVID-19, using a repurposed antiviral AIDS drug for at-home treatment during the first days of symptoms in hopes of slowing the virus early and heading off hospitalization, intensive care, and death. The nationwide clinical trial is being led by Nathan Shapiro,… Read More »